BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 19372780)

  • 1. Qualitative host factors associated with immunological control of HIV infection by CD8 T cells.
    Migueles SA; Tilton JC; Connors M
    Curr Opin HIV AIDS; 2006 Jan; 1(1):28-33. PubMed ID: 19372780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in understanding immunologic control of HIV infection.
    Migueles SA; Tilton JC; Connors M
    Curr HIV/AIDS Rep; 2004 Apr; 1(1):12-7. PubMed ID: 16091218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.
    Ahlers JD; Belyakov IM
    Discov Med; 2010 Jun; 9(49):528-37. PubMed ID: 20587342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HIV-1-specific CD4 T cells.
    Harari A; Cellerai C; Pantaleo G
    Curr Opin HIV AIDS; 2006 Jan; 1(1):22-7. PubMed ID: 19372779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the elite: mechanisms of control in HIV-1 infection.
    O'Connell KA; Bailey JR; Blankson JN
    Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infection.
    Price DA; O'callaghan CA; Whelan JA; Easterbrook PJ; Phillips RE
    Clin Sci (Lond); 1999 Dec; 97(6):707-18. PubMed ID: 10585898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
    Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
    J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responses in primary HIV-1 infection.
    Streeck H; van Bockel D; Kelleher A
    Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic immunization in HIV infection.
    Autran B; Kinloch-de Loes S; Katlama C
    Curr Opin HIV AIDS; 2006 Jul; 1(4):323-9. PubMed ID: 19372828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of HIV-1 replication in elite suppressors.
    Blankson JN
    Discov Med; 2010 Mar; 9(46):261-6. PubMed ID: 20350494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
    Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes and viral adaptation in HIV infection.
    Goulder P; Klenerman P
    Curr Opin HIV AIDS; 2006 May; 1(3):241-8. PubMed ID: 19372816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype and function of protective T cell immune responses in HIV.
    Betts MR; Harari A
    Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
    Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
    AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.